TMJ 'dysfunction' - Health implications

Within this forum, you will discover valuable insights on how a 'dysfunctional' jaw, dental arch anomalies, and various body asymmetries can contribute to illness from a unique perspective. This is your go-to resource for finding effective solutions and achieving lasting relief.
It is currently Fri, 29 Mar 2024, 12:42 pm

All times are UTC [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Sun, 28 Apr 2013, 11:35 am 
Offline
Site Admin

Joined: Fri, 28 Sep 2012, 9:08 pm
Posts: 219
Why does MS have such a big impact on employment? #MSBlog #MSResearch

Kobelt et al. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):918-26.

OBJECTIVE: To assess overall resource consumption, work capacity and quality of life of MSers with MS in nine European countries.

METHODS: Information on resource consumption related to MS, informal care by relatives, productivity losses and overall quality of life (utility) was collected with a standardised pre-tested questionnaire from 13,186 MSers enrolled in national MS societies or followed up in neurology clinics. Information on disease included disease duration, self-assessed disease severity and relapses. Mean annual costs per patient (Euro, 2005) were estimated from the societal perspective.

RESULTS: The mean age ranged from 45.1 to 53.4 years, and all levels of disease severity were represented. Between 16% and 29% of MSers reported experiencing a relapse in the 3 months preceding data collection.

The proportion of MSers in early retirement because of multiple sclerosis ranged from 33% to 45%. The use of direct medical resources (e.g., hospitalisation, consultations and drugs) varied considerably across countries, whereas the use of nonmedical resources (e.g. walking sticks, wheelchairs, modifications to houses and cars) and services (e.g., home care and transportation) was comparable.

Informal care use was highly correlated with disease severity, but was further influenced by healthcare systems and family structure. All types of costs increased with worsening disease. The total mean annual costs per MSer (adjusted for gross domestic product purchasing power) were estimated at Euro 18,000 for mild disease (Expanded Disability Status Scale (EDSS) <4.0), Euro 36,500 for moderate disease (EDSS 4.0-6.5) and Euro 62,000 for severe disease (EDSS >7.0). Utility was similar across countries, at around 0.70 for a patient with an EDSS of 2.0 and around 0.45 for a patient with an EDSS of 6.5. Intangible costs were estimated at Euro 13,000 per patient.


Share on FacebookShare on TwitterShare on TuentiShare on SonicoShare on FriendFeedShare on OrkutShare on DiggShare on MySpaceShare on DeliciousShare on TechnoratiShare on TumblrShare on Google+
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC [ DST ]


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Search for:
Jump to:  
Rules of the BoardThe teamDelete all board cookies
cron
Disclaimer: Please read our Disclaimer of warranties and limitation of liability
Also see information on Intellectual Property Rights
Before posting, please read our Board Rules
Powered by phpBB® Forum Software © phpBB Group